Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT06225141

NCT06225141
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are attending a medical genetics, jaw surgery, or craniofacial (skull and face) surgery appointment as part of care for a rare disease (in France, a condition affecting fewer than 30,000 people) that affects the appearance of your head or neck area
  • You have a confirmed diagnosis of one of these specific conditions: Noonan syndrome, 22q11.2 deletion, Crouzon syndrome, Kabuki syndrome, Pitt Hopkins syndrome, Mowat Wilson syndrome, Cornelia de Lange syndrome, Treacher-Collins syndrome, Goldenhar syndrome, or Silver-Russell syndrome
  • Photographs of your face and/or hands are already being taken as part of your normal care
  • (For control participants — people without a rare disease) You are attending a jaw surgery appointment for a condition unrelated to a rare disease affecting facial appearance, such as a wound or gynecomastia (enlarged breast tissue in males), and photographs are being taken as part of your care

Who may not be able to join:

  • You have had surgery on your face or skull before the first photograph for this study was taken
  • You are under a court-ordered legal protection measure
  • (For control participants) You have a condition that affects the symmetry of your face, such as a dental abscess or a displaced fracture
  • (For control participants) You are being seen or monitored for any condition involving unusual facial features, or such a condition has been suspected

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Imagine Institute
Registry
clinicaltrials_gov
Start date
2 January 2022
Est. completion
2 January 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Relationship between phenotypic characteristics and genotype in rare pathologies associated with dysmorphia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov